Clinical trial
Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis
NCT07146529 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis
- Lead sponsor
- ANRS, Emerging Infectious Diseases
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- September 30, 2025
- Completion date
- September 30, 2036
- Enrollment
- 30,060 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hiv drug resistance, hiv infections, hiv seropositivity